Kobo Biotech Ltd., established in 1992 and formerly known as Avon Lifesciences Ltd, is a manufacturer of active pharmaceutical ingredients (APIs) based in India. The company specializes in producing diketene and its derivatives, which are used in pigments, pharmaceuticals, and pesticides. Kobo Biotech has a significant manufacturing facility in Andhra Pradesh and a biotech plant in Maharashtra, producing pharmaceutical intermediates like pseudoephedrine and ephedrine. The company has established technical collaborations with international partners for technology transfer and has received USFDA approval for its biotech facilities.
The company underwent a substantial acquisition by Arch Pharmalabs Limited, becoming its subsidiary after Arch Pharmalabs acquired a 63.60% stake. Kobo Biotech expanded its global reach by forming Regal Pharma PTE Ltd., a wholly-owned subsidiary in Singapore. The company has been recognized for its innovative products and holds ISO 9002 certification, reflecting its commitment to quality manufacturing. With ongoing developments and expansions, Kobo Biotech continues to enhance its product offerings and market presence.
